π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a Phase II , Open-label , Investigator-initiated Trail of Sequentia...
Status
Unknown
Location
Multiple Locations
Start Date
2019-01-30
Trial ID
NCT03825328
Treatments Being Tested
The purpose of this study is to determine whether albumine-bounded paclitax...
Status
Terminated
Location
Department of Medical Oncology,Cancer Hostpital and Institute,CAMS
Start Date
2013-09
Trial ID
NCT01980810
Treatments Being Tested
Gastric cancer have poor prognosis and majority of patients resistant to 5-...
Status
Completed
Location
Lin Shen
Start Date
2011-04
Trial ID
NCT01336062
Treatments Being Tested
Pancreatic cancer is one of the deadliest tumor types, there is no effectiv...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2017-10-01
Trial ID
NCT03278015
Treatments Being Tested
In this study, we combine Nab-PTX, S-1 and sintilimab as adjuvant regimen t...
Status
Unknown
Location
Department of Surgery, Ruijin Hospital
Start Date
2021-03-01
Trial ID
NCT04781413
Treatments Being Tested
It is a single-center, open-lable, randomized controlled trial to prospecti...
Status
Suspended
Location
Ruijin Hospital
Start Date
2022-07-01
Trial ID
NCT05101616
Treatments Being Tested
Gemcitabine plus cisplatin have been the most studied and used anticancer a...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2017-04-01
Trial ID
NCT03051373
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of nanopa...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2014-04
Trial ID
NCT02124317
Treatments Being Tested
This is a randomized phase II trial comparing the first-line treatment with...
Status
Unknown
Location
Peking University Cancer Hospital and Institute
Start Date
2018-07-17
Trial ID
NCT03636308
Treatments Being Tested